The more pronounced reduction in insulin than glucagon levels observed while on PAS, may be an important pathophysiological mechanism in this iatrogenic diabetes; hence restoring insulin:glucagon ratio by either enhancing insulin secretion or reducing glucagon tone can be a potential therapeutic target in this specific setting. Here, GCG is linked to diabetes mellitus.